Skip to main content
. 2015 Jul 2;12:E104. doi: 10.5888/pcd12.140482

Table 2. Predicted (2020) Deaths and Percentage Change From 2007 to 2020 by Risk and Demographics (Population Growth and Aging Combined) for All Cancer Sites Combined and for the Top 23 Cancers by Race and Sex.

Cancer Site All Races
White
Black
2020, No. % Change From 2007 to 2020
2020, No. % Change From 2007 to 2020
2020, No. % Change From 2007 to 2020
Overall Attributable to
Overall Attributable to
Overall Attributable to
Risk Dem Risk Dem Risk Dem
Males
All cancer sites combined 337,280 15.2 −23.0 38.2 285,800 13.4 −21.4 34.8 38,248 15.7 −32.7 48.3
Brain and other CNS 8,752 19.6 −11.5 31.1 7,920 17.2 −10.0 27.2 530 31.2 −9.1 40.3
Colon and rectum 29,244 8.3 −29.0 37.3 23,568 3.3 −30.7 33.9 4,375 27.9 −19.5 47.4
Esophagus 14,313 33.1 −4.9 38.0 13,010 37.1 2.9 34.1 899 −14.8 −65.3 50.6
Hodgkin lymphoma 680 −3.7 −29.5 25.8 553 −11.0 −33.9 22.9 72 −2.5 −32.1 29.6
Kidney and renal pelvis 9,788 22.9 −14.4 37.3 7,932 13.4 −20.4 33.7 1,032 38.7 −7.3 46.0
Larynx 3,047 5.4 −31.9 37.3 2,512 10.0 −23.6 33.7 468 −14.5 −63.6 49.1
Leukemia 15,006 20.7 −15.5 36.2 13,278 18.7 −14.4 33.1 1,224 27.9 −14.7 42.6
Liver and IBD 20,757 83.0 49.8 33.2 16,216 82.5 52.8 29.7 2,983 87.4 42.8 44.6
Lung and bronchus 91,592 3.7 −37.1 40.8 78,588 2.8 −34.4 37.2 9,817 −0.2 −51.6 51.4
Melanoma 6,728 22.2 −11.4 33.6 6,546 21.0 −8.6 29.6 81 36.7 −4.5 41.2
Myeloma 6,831 17.6 −22.0 39.5 5,403 12.8 −23.6 36.4 1,157 32.5 −16.1 48.7
Non-Hodgkin lymphoma 10,662 −3.1 −39.9 36.8 9,369 −5.8 −39.5 33.7 893 19.2 −23.9 43.1
Oral cavity and pharynx 6,216 12.8 −22.4 35.2 5,389 18.3 −13.4 31.7 698 −9.2 −55.8 46.6
Pancreas 24,339 42.1 3.6 38.4 20,674 39.9 5.1 34.8 2,541 34.2 −14.3 48.6
Prostate 30,914 6.3 −33.9 40.2 24,778 4.7 −32.4 37.1 5,285 7.7 −41.6 49.3
Stomach 6,857 1.5 −35.3 36.8 4,951 −2.9 −36.4 33.5 1,264 6.0 −40.5 46.5
Testis 356 9.1 −3.4 12.4 315 6.9 −1.5 8.3
Thyroid 967 39.3 1.0 38.3 841 39.2 4.8 34.4
Urinary bladder 13,113 36.0 −3.3 39.3 11,946 33.5 −2.8 36.2 887 56.9 8.9 48.0
Females
All cancer sites combined 291,923 8.1 −19.5 27.6 242,196 4.4 −18.4 22.8 36,392 17.5 −24.9 42.3
Brain and other CNS 6,771 14.4 −12.0 26.4 6,050 11.7 −10.1 21.7 438 13.2 −24.1 37.3
Cervix uteri 4,085 1.6 −17.7 19.3 3,032 −0.2 −14.3 14.1 856 6.3 −26.5 32.8
Colon and rectum 24,887 −5.1 −30.2 25.1 19,834 −10.0 −30.1 20.2 3,802 10.1 −32.9 42.9
Corpus and uterus, NOS 10,407 39.6 8.7 30.9 7,847 31.6 6.7 25.0 2,092 61.6 10.6 50.9
Esophagus 3,004 5.7 −23.7 29.4 2,672 12.1 −12.5 24.6 339 −14.9 −58.7 43.9
Female breast 40,434 −0.4 −25.5 25.0 32,065 −5.3 −25.8 20.6 6,683 15.3 −21.6 36.9
Hodgkin lymphoma 490 −13.2 −35.3 22.0 424 −15.3 −33.1 17.8 55 −2.5 −33.6 31.1
Kidney and renal pelvis 5,136 8.4 −19.5 27.9 4,382 5.7 −17.6 23.3 516 8.0 −33.6 41.6
Larynx 863 15.9 −16.0 31.9 747 20.1 −6.1 26.2 118 5.8 −44.1 49.9
Leukemia 10,180 7.2 −17.6 24.8 8,825 5.3 −14.9 20.2 923 3.7 −36.2 39.9
Liver and IBD 8,576 47.8 20.7 27.1 6,853 44.9 22.5 22.4 1,046 55.6 13.8 41.8
Lung and bronchus 76,679 9.0 −22.7 31.7 65,793 5.8 −21.1 26.8 7,926 19.2 −26.6 45.7
Melanoma 3,361 13.7 −9.5 23.2 3,195 12.1 −6.1 18.2 82 6.3 −34.3 40.5
Myeloma 4,811 −5.0 −34.0 29.1 3,611 −8.7 −32.6 24.0 947 −5.0 −51.4 46.3
Non-Hodgkin lymphoma 7,831 −17.8 −43.2 25.5 6,813 −21.1 −42.1 20.9 641 0.0 −39.9 39.8
Oral cavity and pharynx 2,615 2.3 −23.5 25.8 2,230 3.0 −18.5 21.5 232 −20.9 −61.0 40.1
Ovary 16,432 12.4 −16.3 28.7 14,122 7.9 −15.9 23.7 1,398 20.5 −24.0 44.5
Pancreas 23,117 36.1 7.9 28.2 18,999 32.7 9.4 23.3 2,981 37.0 −7.9 44.9
Stomach 4,460 −3.7 −27.8 24.1 3,159 −8.5 −27.4 18.9 822 2.1 −39.5 41.5
Thyroid 1,297 49.4 21.2 28.2 1,006 41.5 18.8 22.7 172 82.5 34.9 47.7
Urinary bladder 4,961 18.1 −6.1 24.2 4,289 16.9 −3.0 19.9 544 16.1 −25.0 41.1

Abbreviations: —, Data not shown because numbers were too small for analysis; Dem, demographics.